Cases & Deals

Bay City Capital fund invests in Altheos

Clients Bay City Capital Fund V

Jones Day advised Bay City Capital Fund V in connection with its purchase of $20 million of Series A Convertible Preferred Stock in a private placement by Altheos, Inc., an early-stage biopharmaceutical company. Additional investors include Atheneos Capital, Canaan Partners, Life Science Angels, and Novo A/S.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.